Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats
AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms. METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we comp...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2006-05, Vol.12 (18), p.2908-2913 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2913 |
---|---|
container_issue | 18 |
container_start_page | 2908 |
container_title | World journal of gastroenterology : WJG |
container_volume | 12 |
creator | Wang, Ya-Jun Sun, Jia-Bang Li, Fei Zhang, Shu-Wen |
description | AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms.
METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot.
RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05).
CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia. |
doi_str_mv | 10.3748/wjg.v12.i18.2908 |
format | Article |
fullrecord | <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4087809</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>22003458</cqvip_id><wanfj_id>wjg200618016</wanfj_id><sourcerecordid>wjg200618016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</originalsourceid><addsrcrecordid>eNpVkc2P0zAQxS0EYsvCnROyENcUfySxc0FC1cIircQFzpbjjNvppk6wnVb73-OqFR-nObw3vzeaR8hbztZS1frjab9dH7lYI9dr0TH9jKyE4F0ldM2ekxVnTFWdFOqGvEppz5iQshEvyQ1vFdeaqxVZ7p9miCPOOMABLcWQIST0CIk6iMsIGCoMw-JgoNYtGehsg4tgM2ZM1KY0ObS5qCfMu2LJeCzaFOjk6RynXAD0EYNNQDcFT6PN6TV54e2Y4M113pKfX-5-bO6rh-9fv20-P1SubliuWuWh6Tvo-2HgduC8E71wFqB3tZXM175TanANWG1b7j1w2QnVa5CuaRrt5S35dOHOS3-AwUHI0Y5mjniw8clMFs3_SsCd2U5HUzOtNOsK4MMFcLLB27A1-2mJoZxsyusFYy3XjLfFxi42F6eUIvg_EZyZc1NnuylNmdKUOTdVVt79e9rfhWs1xfD-ytxNYfsLS3hv3aPHEYwo0bJutPwNTvag_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Ya-Jun ; Sun, Jia-Bang ; Li, Fei ; Zhang, Shu-Wen</creator><creatorcontrib>Wang, Ya-Jun ; Sun, Jia-Bang ; Li, Fei ; Zhang, Shu-Wen</creatorcontrib><description>AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms.
METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot.
RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05).
CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v12.i18.2908</identifier><identifier>PMID: 16718817</identifier><language>eng</language><publisher>United States: Department of General Surgery, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China</publisher><subject>Acute Disease ; Amylases - blood ; Animals ; Apoptosis - drug effects ; Apoptosis - physiology ; Ascites - pathology ; Basic Research ; Ceruletide - adverse effects ; Ceruletide - pharmacology ; Enzyme Activation - drug effects ; Enzyme Activation - physiology ; Hyperlipidemias - blood ; Hyperlipidemias - physiopathology ; In Situ Nick-End Labeling ; Lipids - blood ; Male ; Organ Size - drug effects ; Organ Size - physiology ; Pancreas - drug effects ; Pancreas - enzymology ; Pancreas - pathology ; Pancreatitis - chemically induced ; Pancreatitis - pathology ; Pancreatitis - physiopathology ; Polyethylene Glycols - adverse effects ; Protein Kinase C - physiology ; Rats ; Rats, Sprague-Dawley ; 胰腺炎 ; 蛋白质 ; 蛙皮缩胆囊肽 ; 高血脂</subject><ispartof>World journal of gastroenterology : WJG, 2006-05, Vol.12 (18), p.2908-2913</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>2006 Baishideng Publishing Group Co., Limited. All rights reserved. 2006</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</citedby><cites>FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087809/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087809/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16718817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Ya-Jun</creatorcontrib><creatorcontrib>Sun, Jia-Bang</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Zhang, Shu-Wen</creatorcontrib><title>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms.
METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot.
RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05).
CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.</description><subject>Acute Disease</subject><subject>Amylases - blood</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - physiology</subject><subject>Ascites - pathology</subject><subject>Basic Research</subject><subject>Ceruletide - adverse effects</subject><subject>Ceruletide - pharmacology</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Activation - physiology</subject><subject>Hyperlipidemias - blood</subject><subject>Hyperlipidemias - physiopathology</subject><subject>In Situ Nick-End Labeling</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Organ Size - drug effects</subject><subject>Organ Size - physiology</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - enzymology</subject><subject>Pancreas - pathology</subject><subject>Pancreatitis - chemically induced</subject><subject>Pancreatitis - pathology</subject><subject>Pancreatitis - physiopathology</subject><subject>Polyethylene Glycols - adverse effects</subject><subject>Protein Kinase C - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>胰腺炎</subject><subject>蛋白质</subject><subject>蛙皮缩胆囊肽</subject><subject>高血脂</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc2P0zAQxS0EYsvCnROyENcUfySxc0FC1cIircQFzpbjjNvppk6wnVb73-OqFR-nObw3vzeaR8hbztZS1frjab9dH7lYI9dr0TH9jKyE4F0ldM2ekxVnTFWdFOqGvEppz5iQshEvyQ1vFdeaqxVZ7p9miCPOOMABLcWQIST0CIk6iMsIGCoMw-JgoNYtGehsg4tgM2ZM1KY0ObS5qCfMu2LJeCzaFOjk6RynXAD0EYNNQDcFT6PN6TV54e2Y4M113pKfX-5-bO6rh-9fv20-P1SubliuWuWh6Tvo-2HgduC8E71wFqB3tZXM175TanANWG1b7j1w2QnVa5CuaRrt5S35dOHOS3-AwUHI0Y5mjniw8clMFs3_SsCd2U5HUzOtNOsK4MMFcLLB27A1-2mJoZxsyusFYy3XjLfFxi42F6eUIvg_EZyZc1NnuylNmdKUOTdVVt79e9rfhWs1xfD-ytxNYfsLS3hv3aPHEYwo0bJutPwNTvag_A</recordid><startdate>20060514</startdate><enddate>20060514</enddate><creator>Wang, Ya-Jun</creator><creator>Sun, Jia-Bang</creator><creator>Li, Fei</creator><creator>Zhang, Shu-Wen</creator><general>Department of General Surgery, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China</general><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20060514</creationdate><title>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</title><author>Wang, Ya-Jun ; Sun, Jia-Bang ; Li, Fei ; Zhang, Shu-Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-67fe5b9ebbdd1ad1192b2caeebc4a30f4f977dc5ea8a61ffe13927b8e3c5558f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute Disease</topic><topic>Amylases - blood</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - physiology</topic><topic>Ascites - pathology</topic><topic>Basic Research</topic><topic>Ceruletide - adverse effects</topic><topic>Ceruletide - pharmacology</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Activation - physiology</topic><topic>Hyperlipidemias - blood</topic><topic>Hyperlipidemias - physiopathology</topic><topic>In Situ Nick-End Labeling</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Organ Size - drug effects</topic><topic>Organ Size - physiology</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - enzymology</topic><topic>Pancreas - pathology</topic><topic>Pancreatitis - chemically induced</topic><topic>Pancreatitis - pathology</topic><topic>Pancreatitis - physiopathology</topic><topic>Polyethylene Glycols - adverse effects</topic><topic>Protein Kinase C - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>胰腺炎</topic><topic>蛋白质</topic><topic>蛙皮缩胆囊肽</topic><topic>高血脂</topic><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ya-Jun</creatorcontrib><creatorcontrib>Sun, Jia-Bang</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Zhang, Shu-Wen</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ya-Jun</au><au>Sun, Jia-Bang</au><au>Li, Fei</au><au>Zhang, Shu-Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2006-05-14</date><risdate>2006</risdate><volume>12</volume><issue>18</issue><spage>2908</spage><epage>2913</epage><pages>2908-2913</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To investigate the effects of hyperlipidemia on acute pancreatitis (AP) and the possible mechanisms.
METHODS: Rat models of hyperlipidemia and AP were established by Triton WR1339 and cerulein respectively. Human albumin was used to treat AP complicated by hyperlipidemia. In each group, we compared the histological score, volume of ascites, ratio of pancreatic wet/dry weight, serum amylase (AMY) and pancreatic acinar cell apoptosis. The level of protein kinase C (PKC) membrane translocation in pancreatic tissue was detected by Western blot.
RESULTS: In the hyperlipidemia model established by Triton WR1339, triglyceride (TG) increased remarkably and reached its peak 6 h after injection, and most rats developed mild acute pancreatitis. Histological score, volume of ascites, ratio of wet/dry weight and serum AMY in AP animals with hyperlipidemia were obviously higher than those in AP animals (P 〈 0.05) and decreased after albumin therapy but not significantly (P 〉 0.05). Apoptotic cells detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) increased in AP animals with hyperlipidemia and did not change distinctly after albumin therapy. PKC membrane translocation level increased in AP animals with hyperlipidemia and decreased remarkably after albumin therapy (P 〈 0.05).
CONCLUSION: Hyperlipidemia may induce AP or intensify pancreatic injury. Albumin therapy can not alleviate pancreatic lesion effectively. PKC activation may be one mechanism by which AP is intensified by hyperlipidemia.</abstract><cop>United States</cop><pub>Department of General Surgery, Xuanwu Hospital of Capital University of Medical Sciences, Beijing 100053, China</pub><pmid>16718817</pmid><doi>10.3748/wjg.v12.i18.2908</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2006-05, Vol.12 (18), p.2908-2913 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4087809 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection |
subjects | Acute Disease Amylases - blood Animals Apoptosis - drug effects Apoptosis - physiology Ascites - pathology Basic Research Ceruletide - adverse effects Ceruletide - pharmacology Enzyme Activation - drug effects Enzyme Activation - physiology Hyperlipidemias - blood Hyperlipidemias - physiopathology In Situ Nick-End Labeling Lipids - blood Male Organ Size - drug effects Organ Size - physiology Pancreas - drug effects Pancreas - enzymology Pancreas - pathology Pancreatitis - chemically induced Pancreatitis - pathology Pancreatitis - physiopathology Polyethylene Glycols - adverse effects Protein Kinase C - physiology Rats Rats, Sprague-Dawley 胰腺炎 蛋白质 蛙皮缩胆囊肽 高血脂 |
title | Hyperlipidemia intensifies cerulein-induced acute pancreatitis associated with activation of protein kinase C in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A30%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperlipidemia%20intensifies%20cerulein-induced%20acute%20pancreatitis%20associated%20with%20activation%20of%20protein%20kinase%20C%20in%20rats&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Wang,%20Ya-Jun&rft.date=2006-05-14&rft.volume=12&rft.issue=18&rft.spage=2908&rft.epage=2913&rft.pages=2908-2913&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v12.i18.2908&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200618016%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16718817&rft_cqvip_id=22003458&rft_wanfj_id=wjg200618016&rfr_iscdi=true |